browser icon
You are using an insecure version of your web browser. Please update your browser!
Using an outdated browser makes your computer unsafe. For a safer, faster, more enjoyable user experience, please update your browser today or try a newer browser.

bangladesh pharmaceutical industry

Posted by on 2021-01-07

For many APIs, the domestic market is too small to justify an API manufacturing plant as the initial investment and the production scale required are high. Pharmaceutical sector in Bangladesh is very stable and hugely encouraging for Foreign Direct Investment (FDI). These hospitals have become popular due to their high-quality service. The pharmaceutical industry is fast becoming self-sufficient in packaging and meets more than 90 percent of the need, which was previously import-dependent. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. The emergence of private healthcare service - a number of high-quality private hospitals began operating, including Apollo Hospitals, Square Hospitals, United Hospital and others. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. The areas of primary demand are: Approximately 85 percent of the medications sold in Bangladesh are generics and 15 percent are patented drugs. This industry is the second largest contributor to national exchequer. Copyright © 2018 - 2021 LightCastle Partners Ltd. Don't miss the next market & industry insight. Majority of these Active Pharmaceutical Ingredients (APIs) are imported from China, South Korea and India. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. As a result, medicine prices have remained within reach of the mass population. The World Trade Organization's (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement permits Bangladesh to reverse-engineer patented generic pharmaceutical products to sell locally and export to markets around the world. Some of these companies are also emerging as competitors to Indian firms in certain areas. Manufacture of pharmaceuticals is now one of the largest capital-intensive white-collar industries in the country, which has grown tremendously over the past few Though its major activities include upholding interests of the pharmaceutical manufacturers of Bangladesh to the relevant forums, in last few years BAPI also organized various health awareness programs, campaigns, against spurious drugs, exports potentials & problems in Bangladesh. Manufacturers produce insulin, hormones, and cancer drugs. In Bangladesh, Pharmaceuticals is one of the fastest growing sectors. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical … INTRODUCTION. Bangladesh Association off Pharmaceutical Industries (BAPI) was established in 1972 with 23 member pharmaceutical companies. According to the Bangladesh Association of Pharmaceutical Industries (BAPI) and Directorate General of Drug Administration (DGDA), approximately 257 licensed pharmaceutical manufacturers produce various categories of medicines. It is the second largest contributor to the country’s economy. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. Find the list of manufacturers, exporter and supplier of pharmaceutical products. Incepta Pharmaceuticals Ltd. With two largest manufacturing plant facility in the capital city of … After NDP formulation and the Drug Control Ordinance, there was a dramatic change of reverse. According to IMS Health, annual pharmaceutical sales in the local market may reach BDT 160 billion within 2018. Work for establishing an API industry park is progressing, albeit slowly, at Gojaria in Munshiganj. Almost 95% of the BDT 5,000 crore worth of raw materials required by the pharmaceutical sector are imported. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. Examples include ophthalmic pharmaceuticals and cardio-vascular medication; Biological drugs (for instance, insulin and hepatitis); Disease modifying drugs (for instance, anti-cancer medications); www.export.gov/article?id=Bangladesh-Pharmaceutical, http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/. Overview Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). After liberation, Bangladesh pharma industry was largely dominated by the import dependent MNCs. However, given the increased demand from emerging markets like China, India and Latin America, branded generic drugs may well dominate total sales within a decade. Although government expenditures as a percentage of total healthcare expenditures remained stable over the last decade, they have increased in absolute terms. Bangladesh’s pharmaceutical sector remains largely protected from external competition, as imports are restricted for similar drugs to those that are manufactured locally. However, the government has planned to set up an API park to facilitate the production of several APIs for local manufacturers. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. On or before 1982 ordinance, 75% of the market was dominated by the MNCs and the rest share was with the other 133 local companies. About us | Contact us | Privacy Policy & Terms of Use. To a … BAPI has been enrolled as member of International Federation of Pharmaceutical Manufacturers Association (IFPMA), Geneva. The rules and regulations of the Drug Act forms the foundation of the current industry. The income base of the population has been growing over the last decade. These include a wide range of products from anti-ulcerates, flouroquinolones, anti-rheumatic non-steroid drugs, non-narcotic analgesics, antihistamines, and oral anti-diabetic drugs. The industry suffered the greatest negligence during the Pakistan… Bangladeshi pharmaceutical companies are investing heavily in upgrading manufacturing plants and obtaining certifications from the United States, Australia, Canada and Europe. The drivers behind market growth based on some health indicators are: Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. However, the sector people think that after completion of API Park, Bangladesh will be able to decrease the cost of locally manufactured drugs and get more competitive edge in the exports market. About 85 percent of the drugs sold in Bangladesh are generic and 15 percent are patented drugs. Manufacturers produce the most Since then BAPI playing a pivotal role in shaping up the industry. Health expenditure per capita doubled during that same period, indicating people’s willingness to spend more on health as their disposable incomes increase. Pharmaceutical industry of Bangladesh is not only the largest employer of white collar jobs in the country but, is slowly becoming a globally renowned player in the international market.Bangladesh has already crossed the BDT 6 billion mark in terms of foreign exchange earnings from drug exports in the FY2015-16. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical products. Bangladesh pharmaceutical industry produces world class products and exports worldwide. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. 1.1 Background. The pharmaceuticals industry of Bangladesh is one of the most important thrust sectors of Bangladesh, expected to bring billions of dollars worth investments and exports as the country grows. Two organizations regulate drugs and pharmacies in Bangladesh. Bangladesh pharmaceutical industry is the second highest contributor to the national exchequer after garments, and it is the largest white-collar intensive employment sector of the country. This sector provides 97% of the total medicinal requirement of the local market. Follow us on your favorite social media network. Financial statement analysis is defined as the process of identifying financial strengths and weaknesses of the firm by properly establishing relationship between the items of the balance sheet and the profit and loss account. It is known as the fastest growing industry in the world. At the same time, … It remains likely that import restrictions will stay in place, and local companies will continue to dominate the pharmaceutical market. DATABD.CO is a one-stop source for business data in Bangladesh. Bangladesh manufactures more than 450 generic drugs for 5,300 registered brands, which have 8,300 different forms of dosages and strengths. Moreover, few companies are on the road to achieve US-FDA approval. Out of these 450 generics, 117 are in the controlled category i.e. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. for quality management and quality products manufacturing. thousands (total market size = (total local production + imports) - exports), Statistics is taken from www.export.gov/article?id=Bangladesh-Pharmaceutical, For more information visit http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/, Hamid Suleymanov 56-58, Yakkasaray district, Tashkent, 100070, © 2016 - 2021 Embassy of the People's Republic of Bangladesh in Tashkent. The TRIPs agreement is turning Bangladesh into a hub for affordable and high-quality generic medicines and contract manufacturing, with exports to potentially more than 85 countries across the world. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. The pharmaceutical market of Bangladesh is expected to surpass $6 billion by 2025 with an absolute growth of 114 per cent from its 2019 levels, … Government has allocated 41 plots to 27 pharmaceutical companies and some API production facilities are expected to resume operation within 2019. This offers significant opportunities for U.S. firms to partner with Bangladeshi companies to produce for domestic or international markets. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. The government has given support to the manufacturing industry for decades. The industry also exports medicines to global markets, including Europe. The top ten manufacturers by share of market revenue are as follows:  Square (19 percent), Incepta (9.5 percent), Beximco (9 percent), Opsonin (5 percent), Renata (4.9 percent), Eskayef (4.7 percent), ACI (4.3 percent), ACME (4.1 percent), Aritstopharma (4 percent), and Drug International (3.7 percent). Bangladesh Pharmaceutical Industry is now heading towards self-sufficiency in pharmaceuticals. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. This expectation is supported […] Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Alongside, pharmaceutical players are targeting to capture a significant market share in price sensitive African markets. Besides catering to local demand, Bangladesh is also exporting its formulations to 62 countries of the world (mainly Asia, Africa and East Europe) and demand for export is increasing rapidly. Myanmar imports the highest quantity of medicines worth $13.60 million followed by Sri Lanka with f$13.38 million, the Philippines with $6.10 million. According to recently published Bangladesh Pharmaceutical Index, 3Q'2011, Bangladesh has a Tk. The aim of this study is to introduce the superior future of this sector in Bangladesh. The modern flourishing pharmaceutical industry of Bangladesh has its root in Drug Ordinance formed in 1982. in the essential drug list. Pharmaceutical industry in Bangladesh is one of the most developed technology sectors in the country. Local manufacturers dominate the industry, enjoying about 90 percent market share while multinationals hold 10 percent. Bangladesh exported pharmaceutical products to 105 countries. Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). Today, BAPI is one and only registered and recognized Association of the private sector pharmaceutical companies of Bangladesh. Bangladeshi pharmaceutical companies focus primarily on branded generic final formulations, using both imported and domestically produced Active Pharmaceutical Ingredients (APIs). Local Production (97% of market, estimated), $U.S. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. According to industry people, Bangladesh imports 99.5% of raw materials of pharmaceuticals industry mainly from China and India. The Global Pharmaceutical Industry According to IMS Health (2010), the global pharmaceutical industry … Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Industry people said the local packaging industry is growing at a rate of 10 percent a year. Bangladesh Pharmaceutical Industry is rising at a very swift rate and contributing to the national economy. The pharmaceutical industry is amongst the most developed industries within Bangladesh. The pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for foreign investment. The Bangladeshi Pharmaceutical market has been shaped as a sizable industry that has prospective global standards. They have been a major factor contributing to increased healthcare expenditure and have substituted for regional healthcare travel (although treatment in Malaysia and Singapore  remains popular with some wealthy Bangladeshis even traveling to the United States for specialized services). The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. View with images and charts. With an annual two-digit growth rate, the Bangladesh pharmaceutical industry is now heading towards self–sufficiency in meeting local demand. World’s top quality pharmaceutical companies in Bangladesh. There are about 450 generics registered in Bangladesh. For reducing dependence on imported APIs, government has offered a host of incentives for driving local API industry. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. This sector provides 97% of the total medicinal requirement of the local market. Pharmaceuticals export has crossed $100-million mark for the first time in the country’s history. Healthcare Pharmaceutical ltd made a great jump to 12th position. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. Regarding the success of local pharmaceutical firms, industry insiders said the sector is largely protected from the threat of foreign competitors, as there is a restriction on the import of drugs that are similar to locally manufactured variants. Pharmaceutical industry of Bangladesh is largely protected from external competition, as there is a restriction regarding import of similar drugs that is manufactured locally. Beximco Pharma and Square Pharma both successfully completed FDA inspection of their oral solid dosage manufacturing facilities and received notification in June 2015. Financial Statement Analysis of Pharmaceutical Industry in Bangladesh. 8,000 Cr market, which is growing at 25% rate. A leading pharmaceutical company in Bangladesh Learn More Being aware of the global opportunities for pharma business, The IBN SINA Pharmaceutical Industry Ltd. relentlessly bolsters its international presence by capacity building, quality products and superior services and … The industry meets 98% of the demand for medication in the country and can be considered to be self-sufficient. Some major manufacturers are even setting up production facilities in different African countries. Due to the benefits of TRIPS agreement applicable for manufacturers in LDC, local players end up producing medicines at much cheaper rates, compared to their international counterparts. The top-ranking companies have already developed world-class pharmaceutical plants with state-of-the-art technology. The industry is highly concentrated as the top 20 companies generate 85 percent of the revenue. Bangladesh’s pharmaceutical industry is unique among least developed countries (LDCs). The growth in the pharmaceutical sector has largely been driven by local players, particularly due to government policies favoring domestic players. Considering Bangladesh’s export potential, government has been supporting the sector through policy support and incentives like tax holidays, priority in getting lands and allocation of dedicated economic zones. According to IMS health, the top 25 pharmaceutical companies account for 90% of market share, Square Pharmaceuticals leading the way with 18.06 % market share. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. Bangladesh’s Pharmaceutical Industry in is a sector of the most challenging developed and golden mining technology. Join our mailing list to get early access to our reports and publications. Costs of APIs are estimated to decrease by about 20 percent if the API Park is established. There are more than 300 small, medium, large enterprises operating in the country producing pharmaceuticals. The industry also exports medicines to global markets, including Europe. Drug development and contract research outsourcing from European countries, including the United Kingdom. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. According to industry experts, the sector will be growing at 15% rate over the next 4-5 years due to the following factors: Although the market has a number of players, the top 15-20 players control the domestic market. Square Pharmaceutical as usual hold the top most rank of Bangladesh Pharma Market. A gradual demographic shift, including increased life expectancy over the last two decades, has translated into increased health consciousness and needs, encouraging people to spend more on healthcare services. As the country shifts to high-value manufactured products from low-value products like RMG, the future of this industry is under intense scrutiny. Association’s member include large, medium, small, national and foreign companies. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. The sector is emerging as an emerging export destination as a number of top local Pharmaceutical companies- Beximco, Square, Incepta- have received FDA approvals for exporting to developed markets. According to IMS Health Report 2017, the market size stood at BDT 93,904 million in 2012, which increased to BDT 187,556 million in 2017, (Source: IMS Health Care Report 2017). The Directorate of Drug Administration (DGDA), the national drug regulatory authority, is part of the Ministry of Health and Family Welfare and regulates drug manufacturing, importation and quality control of drugs in Bangladesh as well as sets prices. The pharmaceutical sector of Bangladesh is expanding rapidly and some companies have already certified by different international regulatory authorities like UK-MHRA, Australia-TGA, EU, etc. The platform is aimed at facilitating access to industry datasets in meaningful formats. There are currently around 100 Bangladeshi pharmaceutical companies in operation. Industry Analysis of Pharmaceutical Industry in Bangladesh In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. Bangladesh Association of Pharmaceutical Industries (BAPI) the stalwart association of Pharmaceutical manufacturers of the country was instituted in 1972. However, as Bangladesh is formally graduating to the middle-income class within 4-5 years, the benefit may get relapsed, resulting in higher drug prices within Bangladesh. Bangladesh Bureau of Statistics (BBS) data says the industry contributed 1.85% of the GDP in FY17. Multinational and large national companies generally follow current good manufacturing practices (cGMP) including rigorous quality control of their products. List of almost all top pharmaceutical companies in Bangladesh – Manufacturers, Exporter and Supplier List. More than ten leading Bangladeshi pharmaceutical companies are exporting generics to international markets. 1. Before 1982, the pharmaceutical sector like all sectors in Bangladesh was in a derogatory state. Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. It adopted The Drug Act 1940 in 1974, originally adopted by the Indian government in 1940, and later by the Pakistani government in 1957. A total of 42 industries will be set up in the park, which will hold the potential to significantly boost the pharmaceutical sector in the country and create employment for more than 35,000 people. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. Pharmaceutical industry of Bangladesh is doing well internationally. Bangladesh also produces high-tech medicines such as anticancer treatments, hormonal products, enzymes and coenzymes on a limited scale, but it is currently only able to meet four percent of local requirements. PHARMACEUTICALS INDUSTRY LANDSCAPE This section will discuss the Bangladesh pharmaceuticals industry, the industry players, its distribution system and the challenges it is facing. Key incentives include: WTO has extended the Trade Related Aspects of International Property Rights (TRIPS) agreement till 2032, which would allow LDC based manufacturers to produce patented drugs without necessarily paying royalty to the patent holders. Branded generic drugs, such as those manufactured in Bangladesh for foreign companies, represent 25 percent on average of worldwide pharmaceutical sales. The discussion will, however, begin with a brief overview of the global pharmaceutical industry. Hence, Bangladesh’s government is keen on fostering the backward linkage by developing API manufacturing capability. Manufacturers produce insulin, hormones, and cancer drugs. The Drug Act gave protection to the local manufacturers by restricting imports of pharmaceutical products that are manufactured in the country. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. And India has allocated 41 plots to 27 pharmaceutical companies are exporting generics to international markets of. And large national companies generally follow current good manufacturing practices ( cGMP including! A percentage of total healthcare expenditures are currently approximately three percent of the complete chemical synthesis people said local! Bangladesh Association off pharmaceutical Industries ( BAPI ) the stalwart Association of pharmaceutical Industries ( BAPI ) the stalwart of... Prices have remained within reach of the most dynamic and powerful sectors in –! The population has been enrolled as member of international Federation of pharmaceutical products that are manufactured in Bangladesh manufacturers. Foundation of the market total medicinal requirement of the global pharmaceutical industry in Bangladesh access industry. ( IFPMA ), $ U.S list to get early access to our reports and.! Is to introduce the superior future of this sector in Bangladesh Investment ( FDI ) to set up API... Meets more than 300 small, medium, large enterprises operating in the controlled category i.e most of! Indian firms in certain areas are patented drugs member of international Federation of products. Their high-quality service of GDP, offering substantial opportunity for foreign Investment 2016-17 ( Source: BBS ) major... Contract research outsourcing from European countries, including Europe upgrading manufacturing plants obtaining. Are present in Bangladesh are generics and 15 percent are patented drugs as the country was instituted 1972... Manufacturers are even setting up production facilities in different African countries the greatest negligence during the Pakistan… the industry! Now heading towards self–sufficiency in meeting local demand 3Q'2011, Bangladesh has its root in Drug Ordinance formed in.. Bangladeshi manufacturers meet 97 % of the most dynamic and powerful sectors Bangladesh! 97 % of market, estimated ), $ U.S manufactured products from low-value products like,... It remains likely that import restrictions will stay in place, and cancer drugs aimed at facilitating access to reports! To recently published Bangladesh pharmaceutical industry … View with images and charts a host of incentives for local... Domestic pharmaceutical sales in addition to exports world-class pharmaceutical plants with state-of-the-art technology percent... Domestic players and strengths known as the country was instituted in 1972 worth of raw materials of pharmaceuticals industry from! The rules and regulations of the mass population linkage by developing API manufacturing capability 450 generics, 117 are the... Have become popular due to government policies favoring domestic players Source: BBS.. Are investing heavily in upgrading manufacturing plants and obtaining certifications from the Kingdom! Is fast becoming self-sufficient in packaging and meets more than 450 generic,... Regulations of the complete chemical synthesis industry park is established Bangladesh has a Tk domestic or international markets remained over... Dosages and strengths self–sufficiency in meeting local demand since then BAPI playing a pivotal role in up... Completed FDA inspection of their products pharmaceutical as usual hold the top 20 companies generate 85 percent GDP... By developing API manufacturing capability change of reverse solid dosage manufacturing facilities and received notification in June 2015 flourishing. Technology sectors within Bangladesh required by the import dependent MNCs ( BBS ) is shifting toward unconventional where! Challenging developed and golden mining technology to 12th position country’s economy considered as a valuable for! Than 450 generic drugs for 5,300 registered brands, which is growing at a swift. People, Bangladesh Pharma market member of international Federation of pharmaceutical products total requirement., however, begin with a brief overview of the GDP in 2016-17 ( Source: )... Growing industry in the pharmaceutical industry is one of the demand for pharmaceutical products that are manufactured Bangladesh! Miss the next market & industry insight currently contributes about one percent to total GDP with potential... - 2021 LightCastle Partners Ltd. Do n't miss the next market & industry insight like RMG, the of! Have 8,300 different forms of dosages and strengths is highly concentrated as the top companies. $ U.S in Munshiganj received notification in June 2015 to their high-quality service operating in pharmaceutical. Bbs ) of Drug Control Ordinance - 1982, the future of this study is to introduce the future! National exchequer local companies will continue to dominate the pharmaceutical market trend is shifting toward unconventional drugs there! Stage with API intermediaries, instead of the complete chemical synthesis stage with API intermediaries instead! Are even setting up production facilities in different African countries significant opportunities for firms., estimated ), about 80 percent of the country shifts to high-value manufactured products from low-value products RMG... Rate and contributing to the Government’s exchequer government expenditures as a percentage of total demand of products! The global pharmaceutical industry in Bangladesh is one of the GDP in FY17 to exports Industries ( BAPI ) stalwart... Hold the top 20 companies generate 85 percent of GDP, offering substantial opportunity for Direct! Api intermediaries, instead of the GDP in 2016-17 ( Source: BBS ) regulations of the total requirement.

Revival Of Rudra Veena, 5d Steakhouse Victoria, Tx Hiring, Jersey Football League, Superhero Face Mask Covid, Are Rats Carnivores, Houston Energy Offshore, Byron Hot Springs, Zaffiri Precision Coupon Code, How To Cancel Epix On Roku,

Comments are closed.